In the current study we want to obtain fundamental insight in the role of insulin-mediated glycocalyx modulation as well as the effect of FFAs on this mechanism. We propose that increased levels of FFA degrade the glycocalyx and result in an…
ID
Source
Brief title
Condition
- Diabetic complications
- Arteriosclerosis, stenosis, vascular insufficiency and necrosis
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Increase of capillary blood volume by hyperinsulinemia
Recruitment of glycocalyx volume
Effects of FFA infusion
Secondary outcome
Glycocalyx changes (SDF)
Glucose uptake
Endothelial function
Glycocalyx degradation products
NO bioavailability
Background summary
There is strong support for the notion that free fatty acids (FFAs) are an
important link between obesity, insulin resistance and type 2 diabetes. Recent
finding suggest also a role for the microcirculation in the insulin mediated
glucose disposal in peripheral tissues. In this study we will examine insulin
mediated glucose disposal under different levels of FFAs and look at the
endothelial glycocalyx, a highly hydrated mesh on the endothelium. We
hypothesize that insulin mediates capillary blood volume by glycocalyx
modulation and that FFA interfere with this process.
Study objective
In the current study we want to obtain fundamental insight in the role of
insulin-mediated glycocalyx modulation as well as the effect of FFAs on this
mechanism. We propose that increased levels of FFA degrade the glycocalyx and
result in an impaired insulin mediated increase in capillary blood volume. This
will concurrently result in decreased glucose disposal.
Study design
Ten lean male subjects will be studied 3 times after an overnight fast. Micro-
and macrovasculature will be studied in a hyperinsulinemic euglycemic clamp
combined with each visit a different level of FFAs. After a period of one week
subjects will undergo the second study using the same protocol as in the first
study (but with a different level of FFA).
All studies will be performed in healthy volunteers and a pilot study will be
performed for power analysis. All volunteers will undergo a hyperinsulinemic
euglycemic clamp. Within this clamp they will be faced with three levels of
FFA: normal, postprandial and diabetic levels.
Intervention
1. Clamp with FFAs: placebo, postprandial en diabetic levels through Intralipid
infusion.
2. Hyperinsulinemic clamp after 4 hours of FFA clamp
3. Capillary volume measurements: infusion of haes 6% arterially and venous
sampling. Before and after hyperinsulinemic clamp.
4. Flow mediated dilation (FMD) brachial artery (non invasive). Before FFA
clamp and before hyperinsulinemic clamp.
5. Veneuze plethysmografie: non-invasieve method to determine arterial flow.
6. Sidestream Darkfield (SDF) beeldvorming. During the entire protocol every
hour a 5 minute recording of the sublingual microcirculation is made.
Study burden and risks
Although the protocol is extensive there is only a minimal risk involved. The
arterial line will be inserted by trained personel aswell as the venous
catheters. Infusio of Intralipid is by using heparin heparine minimized in
dose and a hyperinsulinemic euglycemisc clamp is a low risk procedure.
Meibergdreef 9
1105 az
Nederland
Meibergdreef 9
1105 az
Nederland
Listed location countries
Age
Inclusion criteria
Healthy male
age between 18 and 35 years old
Exclusion criteria
diabetes
hypertension
smoking
cardiovascular disease
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL21557.018.08 |